Literature DB >> 8385113

Cross-linking identifies leukemia inhibitory factor-binding protein as a ciliary neurotrophic factor receptor component.

N Stahl1, S Davis, V Wong, T Taga, T Kishimoto, N Y Ip, G D Yancopoulos.   

Abstract

Ciliary neurotrophic factor (CNTF) and leukemia inhibitory factor (LIF) are cytokines that give rise to an identical set of tyrosine-phosphorylated proteins upon addition to responsive cells. One of these proteins is the interleukin-6 signal-transducing molecule gp130, which is required for signal transduction by both CNTF and LIF. Here we identify another prominent tyrosine-phosphorylated protein as LIF receptor (LIFR) beta, which was originally cloned as a LIF-binding protein. Cross-linking experiments with iodinated factors were carried out on a cell line responsive to CNTF and LIF, as well as on COS cells that were cotransfected with various combinations of gp130, LIFR beta, and CNTF receptor (CNTFR) alpha, the previously cloned CNTF-binding protein. These experiments reveal that LIF cross-links to LIFR beta alone, as well as to gp130 when it is coexpressed with LIFR beta. However, cross-linking of CNTF to LIFR beta and gp130 is only observed in the presence of CNTFR alpha. These and other data show that the two known LIF receptor components are recruited by CNTF and CNTFR alpha to form a trimeric CNTF receptor complex.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385113

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Regulation of neurokine receptor signaling and trafficking.

Authors:  Neil M Nathanson
Journal:  Neurochem Int       Date:  2012-01-25       Impact factor: 3.921

2.  Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow.

Authors:  S C Lin; T Yamate; Y Taguchi; V Z Borba; G Girasole; C A O'Brien; T Bellido; E Abe; S C Manolagas
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 3.  Inflammation and axonal regeneration.

Authors:  P M Richardson; X Lu
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

Review 4.  Activating mechanism of CNTF and related cytokines.

Authors:  M Inoue; C Nakayama; H Noguchi
Journal:  Mol Neurobiol       Date:  1996-06       Impact factor: 5.590

5.  Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination.

Authors:  Ben Emery; Holly S Cate; Mark Marriott; Tobias Merson; Michele D Binder; Cameron Snell; Pik Ying Soo; Simon Murray; Ben Croker; Jian-Guo Zhang; Warren S Alexander; Helen Cooper; Helmut Butzkueven; Trevor J Kilpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

Review 6.  Humanin and the receptors for humanin.

Authors:  Masaaki Matsuoka; Yuichi Hashimoto
Journal:  Mol Neurobiol       Date:  2009-12-09       Impact factor: 5.590

Review 7.  Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration.

Authors:  Suzan Dziennis; Nabil J Alkayed
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

8.  Human ciliary neurotrophic factor: a structure-function analysis.

Authors:  A Krüttgen; J Grötzinger; G Kurapkat; J Weis; R Simon; M Thier; M Schröder; P Heinrich; A Wollmer; M Comeau
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

9.  Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor.

Authors:  D P Gearing; S F Ziegler; M R Comeau; D Friend; B Thoma; D Cosman; L Park; B Mosley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

10.  Systemic administration of ciliary neurotrophic factor induces cachexia in rodents.

Authors:  J T Henderson; N A Seniuk; P M Richardson; J Gauldie; J C Roder
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.